EXPLORING THE ANTI-INFLAMMATORY PROPERTIES OF METFORMIN IN EXPERIMENTAL HEMORRHOID MODELS

Authors

  • DARMAWI DARMAWI 1 Department of Histology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  • MUHAMMAD YULIS HAMIDY 2 Department of Pharmacology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia https://orcid.org/0000-0003-3412-4063
  • SORAYA SORAYA 3 Master Program in Biomedical Sciences, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  • NURUL AZIZAH 3 Master Program in Biomedical Sciences, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  • LALU MUHAMMAD IRHAM Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • BAIQ LENY NOPITASARI Department of Pharmacy, Faculty of Health Science, Universitas Muhammadiyah Mataram, Mataram, Indonesia
  • INA F. RANGKUTI Department of Pathology Anatomy, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  • A. A. MUHAMMAD NUR KASMAN Research Center for Applied Zoology, Research Organization for Life Sciences and Environment, National Research and Innovation Agency (BRIN), Cibinong, Indonesia. 8 Department of Midwifery, Faculty of Health Science, Universitas Muhammadiyah Mataram, Mataram, Indonesia https://orcid.org/0000-0003-2511-4920
  • WIRAWAN ADIKUSUMA 5 Department of Pharmacy, Faculty of Health Science, Universitas Muhammadiyah Mataram, Mataram, Indonesia. 9 Research Center for Computing, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRIN), Cibinong, Indonesia https://orcid.org/0000-0001-9165-690X

DOI:

https://doi.org/10.22159/ijap.2025v17i2.53174

Keywords:

Anti-inflammatory effects, Gene expression, Hemorrhoids, Leukocyte infiltration, metformin

Abstract

Objective: This study investigated the anti-inflammatory potential of metformin as a therapeutic agent in an experimental hemorrhoid model using Sprague-Dawley rats.

Methods: Rats were assigned to six groups: normal control, negative control (hemorrhoid-induced without treatment), positive control (hemorrhoid-induced and treated with aspirin), and three metformin-treated groups receiving 3 mg/kg, 9 mg/kg, and 15 mg/kg body weight doses. Metformin's effects were assessed through macroscopic observation, qPCR analysis of IL-6, TNF-α, IL-10, and COX-2 gene expression, and histopathological examination of leukocyte infiltration and venule diameter.

Results: qPCR analysis revealed significant reductions in IL-6 and TNF-α expression in metformin-treated groups compared to the negative control. Specifically, the 9 mg/kg dose achieved a 99% reduction in IL-6 and over 98% reduction in TNF-α expression. COX-2 expression was also significantly decreased in metformin-treated groups (p<0.0001), while IL-10 expression remained unchanged (p=0.3973). Histopathological analysis showed a dose-dependent reduction in leukocyte infiltration, with the 15 mg/kg dose exhibiting the most significant decrease (p<0.0001). Additionally, metformin treatment resulted in a significant reduction in venule diameter, particularly at the 15 mg/kg dose (p<0.0001).

Conclusion: These results suggest that metformin, especially at higher doses, has significant anti-inflammatory effects in experimental hemorrhoid models, indicating its potential as a promising therapeutic option for hemorrhoid treatment.

Downloads

Download data is not yet available.

References

Gupta, S., et al. RECENT MANAGEMENT OF HEMORRHOIDS : A PHARMACOLOGICAL & SURGICAL PERSPECTIVE. 2020.

Ray-Offor, E. and S. Amadi, Hemorrhoidal disease: Predilection sites, pattern of presentation, and treatment. Ann Afr Med, 2019. 18(1): p. 12-16.

Al-Masoudi, R.O., et al., Prevalence of Hemorrhoids and the Associated Risk Factors Among the General Adult Population in Makkah, Saudi Arabia. Cureus, 2024. 16(1): p. e51612.

Carlos Sardiñas, Dilia Diaz Arreaza, and H. Osorio, Changes in the proportions of types I and III collagen in hemorrhoids: the sliding anal lining theory. Journal of Coloproctology, 2016. 36(3): p. 124-129.

Zhifei Sun and J. Migaly, Review of Hemorrhoid Disease: Presentation and Management. Clinics in Colon and Rectal Surgery, 2016. 29(1): p. 22-29.

Sanchez, C. and B.T. Chinn, Hemorrhoids. Clin Colon Rectal Surg, 2011. 24(1): p. 5-13.

Lohsiriwat, V., Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol, 2012. 18(17): p. 2009-17.

Porwal, A., P. Gandhi, and D. Kulkarni, Laser Hemorrhoidopexy: An Observational Study of 1088 Patients Treated at Single Center. Indian Journal of Colo-Rectal Surgery, 2022. 5(3): p. 61-67.

Ng, K.S., M. Holzgang, and C. Young, Still a Case of "No Pain, No Gain"? An Updated and Critical Review of the Pathogenesis, Diagnosis, and Management Options for Hemorrhoids in 2020. Ann Coloproctol, 2020. 36(3): p. 133-147.

Altomare, D.F. and S. Giuratrabocchetta, Conservative and surgical treatment of haemorrhoids. Nat Rev Gastroenterol Hepatol, 2013. 10(9): p. 513-21.

Zagriadskii, E.A., A.M. Bogomazov, and E.B. Golovko, Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study. Adv Ther, 2018. 35(11): p. 1979-1992.

Tseng, C.H., Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus. Front Pharmacol, 2020. 11: p. 578831.

Zhou, J., et al., Metformin: An Old Drug with New Applications. Int J Mol Sci, 2018. 19(10).

Saisho, Y., Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocr Metab Immune Disord Drug Targets, 2015. 15(3): p. 196-205.

Kelly, B., et al., Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages. J Biol Chem, 2015. 290(33): p. 20348-59.

Wang, Q., et al., Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission. Diabetes, 2017. 66(1): p. 193-205.

Karimi, H., et al., Effects of Metformin on Experimental Varicocele in Rats. Arch Razi Inst, 2021. 76(2): p. 371-384.

Nurul Qurrota, A., et al., Anti-Inflammation of Soursop Leaves (Annona muricata L.) Against Hemorrhoids in Mice Induced by Croton Oil. Pharmacognosy Journal, 2020. 12(4).

Hutagalung, M.S.B., et al., Phlebotrophic Effect of Graptophyllum Pictum (L.) Griff on Experimental Wistar Hemorrhoids. 2019, 2019: p. 4.

Livak, K.J. and T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001. 25(4): p. 402-8.

Wanchaitanawong, W., et al., Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic. Int Immunopharmacol, 2022. 112: p. 109230.

Dey, Y.N., et al., Curative effect of Amorphophallus paeoniifolius tuber on experimental hemorrhoids in rats. J Ethnopharmacol, 2016. 192: p. 183-191.

Fontem, R.F. and D. Eyvazzadeh, Internal Hemorrhoid, in StatPearls. 2024: Treasure Island (FL).

Gallo, G., et al., Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review. Updates Surg, 2024. 76(2): p. 423-434.

Kaidar-Person, O., B. Person, and S.D. Wexner, Hemorrhoidal disease: A comprehensive review. J Am Coll Surg, 2007. 204(1): p. 102-17.

Ahmadu, A.A., A.U. Zezi, and A.H. Yaro, Anti-diarrheal activity of the leaf extracts of Daniellia oliveri Hutch and Dalz (Fabaceae) and Ficus sycomorus Miq (Moraceae). Afr J Tradit Complement Altern Med, 2007. 4(4): p. 524-8.

Adikusuma, W., et al., Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment. Saudi Pharm J, 2023. 31(12): p. 101831.

Kulkarni, A.S., S. Gubbi, and N. Barzilai, Benefits of Metformin in Attenuating the Hallmarks of Aging. Cell Metab, 2020. 32(1): p. 15-30.

Shi, B., et al., Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2. Oncol Lett, 2021. 22(2): p. 615.

Lin, H., et al., The Role and Mechanism of Metformin in Inflammatory Diseases. J Inflamm Res, 2023. 16: p. 5545-5564.

Cameron, A.R., et al., Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circ Res, 2016. 119(5): p. 652-65.

Apostolova, N., et al., Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol, 2020. 34: p. 101517.

Sigit Adi, P., B. Parish, and R. Ignatius, Prolapsing Hemorrhoids, in Benign Anorectal Disorders, V. Alberto and L. Daniela Cornelia, Editors. 2022, IntechOpen: Rijeka. p. Ch. 3.

Published

27-12-2024

How to Cite

DARMAWI, D., HAMIDY, M. Y., SORAYA, S., AZIZAH, N., IRHAM, L. M., NOPITASARI, B. L., RANGKUTI, I. F., KASMAN, A. A. M. N., & ADIKUSUMA, W. (2024). EXPLORING THE ANTI-INFLAMMATORY PROPERTIES OF METFORMIN IN EXPERIMENTAL HEMORRHOID MODELS. International Journal of Applied Pharmaceutics, 17(2). https://doi.org/10.22159/ijap.2025v17i2.53174

Issue

Section

Original Article(s)